MarketPulse
C

$CASBF

1 article found
0 positive
0 negative
1 neutral
BenzingaBenzinga··Bamboo Works

CanSino Rebounds on Meningitis Vaccine Success, But Concentration Risk Looms

CanSino reports 26% growth and profitability rebound on meningitis vaccine success, but faces concentration risk and rising competitive threats in China's declining vaccine market.
CASBFcompetitionSoutheast Asia expansion